SFI Health Ther-Biotic Complete has a specific product identity that matters more than the broad word probiotic. This review follows its vegetarian capsules, ingredient account, potency wording and purchase record. It asks what those details establish, and what remains uncertain, for someone comparing digestive-support products while keeping prescription care separate.
The most useful distinction in this record is straightforward: The detailed species quantities are useful, but strain-level matching and the medication warning remain important. A professional purchasing pathway does not itself constitute individualized clinical approval. The following sections keep the manufacturer's statements beside their qualifications. They do not claim firsthand use, a tested shipment, a completed transaction or a clinical recommendation for an individual.
The context to keep
The detailed species quantities are useful, but strain-level matching and the medication warning remain important. A professional purchasing pathway does not itself constitute individualized clinical approval.
The exact product and package — SFI Health
The Klaire official record, reviewed here as SFI Health’s Ther-Biotic Complete, names SKU V775-06 with 60 vegetarian capsules. A 120-capsule package and powder are separately listed; this is one brand. Official SFI Health record
A product family can contain several formulas even when its packaging looks familiar. The selected name, format and package description therefore belong together. A capsule, chewable or liquid variant may have different organisms, supporting ingredients and commercial terms. A useful comparison begins with the item actually described, rather than borrowing a stronger headline from somewhere else in the catalog. The identity is also what allows a reader to ask a precise question about the bottle or label offered to them.
What the ingredient account supplies
Its label describes twelve bacterial species in a chicory-inulin base, with a vegetarian capsule, proprietary polysaccharide complex and L-leucine. Named species are not the same as complete strain identifiers. Official SFI Health record
Two products may use the same broad bacterial family without containing the same researched strain. NIH’s labeling discussion makes strain identification a useful part of a comparison, rather than an optional flourish. The supporting base belongs in that discussion too: a coating, fiber, sweetener or capsule material is different from the microorganism itself. A short highlight list does not establish everything in the preparation. It also does not settle an allergy question or demonstrate the absence of ingredients not shown. Read the NIH labeling context. The package-version guide discusses why a matching name is only the start.
What the quantities can establish
The capsule panel prints a 255 mg blend and 25 billion CFU, with individual species counts. The powder’s separate narrative uses different quantity wording; it is not transferred to the capsule. Official SFI Health record
The potency headline needs its unit and qualification before it can be compared with another product. NIH distinguishes live-cell counts from microbial mass and notes that larger counts are not necessarily more effective. The timing of a stated guarantee is equally relevant. A value measured during manufacture does not become an expiration guarantee through repetition in marketing. Likewise, the count of strains is not a substitute for CFU. The review keeps these quantities separate without suggesting an amount for an individual to take. Read the NIH labeling context.
Claims beside their evidence — SFI Health
InTactic delivery and immune or barrier support are manufacturer claims. General digestion references and component research do not automatically establish a whole-formula result during GLP-1 treatment. Official SFI Health record
Evidence has a product, population and outcome attached to it. Research on an identified organism may be relevant background while still differing from a finished blend. A customer’s description of comfort answers another question again. NCCIH notes that effects vary with the type of probiotic and the condition studied. A complete assessment would need the actual report, comparison group and outcome methods. The manufacturer’s wording is therefore reported as its account, without promising the same result or treating it as evidence for every digestive complaint. Read the NCCIH evidence and safety context.
The container question that stays open
The page describes temperature-control shipping and refrigeration, while its caution expressly says the product should not replace medication. No private professional technical information was accessed. Official SFI Health record
Refrigeration, shelf stability and protective packaging are statements about different parts of the product story. They can concern the manufacturer’s intended conditions or transport process without measuring the cells in a delivered bottle. An assurance about a product family may also have a narrower scope than it first appears. Keeping the item-specific qualification visible avoids borrowing a handling rule from another preparation. This is an account of what the company describes, rather than a temperature protocol or confirmation that a shipment retained its claimed potency. The handling-and-delivery guide keeps those source scopes separate. For another product record, read MegaFood MegaFlora Probiotic Original without assuming the same conditions apply.
Commercial details without a completed order
The selected 60-capsule US record displayed $52.99. Different counts and powder are distinct purchase units, and a displayed amount does not confirm local stock or delivery. Official SFI Health record
The purchase record should be read in its own units: selected container, one-time or recurring charge, shipment and any guarantee period. These can vary within one page. A product listing does not prove that a local retailer has stock, and an available message is not a completed transaction. The review does not calculate a personal course of use from the container. Its purpose is to preserve what the offer actually says so that price and quantity are not mistaken for medical value or a delivery promise. The purchase-terms guide considers the offer itself. The Bio-K+ review provides a separate named product comparison.
The useful question for care
The detailed species quantities are useful, but strain-level matching and the medication warning remain important. A professional purchasing pathway does not itself constitute individualized clinical approval. Official SFI Health record
FDA explains that dietary supplements are not approved before marketing and that manufacturers have responsibilities for their claims. That regulatory context is different from independent validation of this preparation. It also does not decide whether the product is appropriate during an individual’s prescribed treatment. NCCIH identifies particular safety concerns for people with serious illness or compromised immunity. Questions involving a medicine, diagnosis or changing symptoms belong with the responsible care professional, with the exact product label available for discussion rather than a category-wide assumption. Read the NCCIH evidence and safety context. FDA oversight explanation. The serious-illness and immunity guide explains the care boundary in more detail.